After gains of 5.0% this afternoon, Catalent shares are now trading at $45.6. Read below for the essential facts about this stock:
-
Catalent has logged a -8.8% 52 week change, compared to 20.4% for the S&P 500
-
CTLT has an average analyst rating of buy and is -7.09% away from its mean target price of $49.08 per share
-
Its trailing earnings per share (EPS) is $-5.61, which brings its trailing Price to Earnings (P/E) ratio to -8.1. The Health Care sector's average P/E ratio is 30.21
-
The company's forward earnings per share (EPS) is $1.6 and its forward P/E ratio is 28.5
-
The company has a Price to Book (P/B) ratio of 2.14 in contrast to the Health Care sector's average P/B ratio is 4.08
-
The company's free cash flow for the last fiscal year was $-563000000 and the average free cash flow growth rate is -15.3%
-
Catalent's revenues have an average growth rate of 13.3% with operating expenses growing at 11.3%. The company's current operating margins stand at 3.9%